FdaApplication
ANDA 204982
Identifiers
- fda_app_no: ANDA204982
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC |
| application_type | ANDA |
| approval_date | 2024-06-25 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 15MG BASE;92MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 3.75MG BASE;23MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 11.25MG BASE;69MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | EQ 7.5MG BASE;46MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products